We have focused on developing our business through organic growth and by expanding through acquisitions. In 2018 AddLife took an important step toward expansion and growth. Through our largest acquisition to date, Austrian Biomedica, we opened the door to Europe. The four other acquisitions completed during the year further strengthened the company within the prioritized niche areas. Together, the five acquisitions for the year are expected to add annual sales of about SEK 750 million.
Labtech offers products and services to diagnostics and biomedical research and laboratory analysis.
MORE ABOUT LABTECHMedtech offers medical device products to the publicly funded health care primarily in the Nordic countries and the rest of Europe.
MORE ABOUT MEDTECHWe develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.
MORE ABOUT AQUISITIONSAddLife is a leading independent distributor to the European Life Science market. The business focuses on selected niches in laboratory analysis and medical technology. Sales occur in about 25
countries, primarily in the Nordic region, Central Europe and Eastern Europe.
Our customers are primarily hospitals and laboratories, as well as the food and pharmaceutical industries.
AddLife´s business concept is to add value to customers within healthcare, laboratories and research. We shall achieve this by offering cost efficient high quality products and solutions combined with qualified advisory services to the private and public sector in the Nordic countries and the rest of Europe.
MORE ABOUT ADDLIFE
